Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2003
12/18/2003WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003WO2003103571A2 Flavivirus vaccines
12/18/2003WO2003103570A2 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
12/18/2003WO2003103478A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
12/18/2003WO2003103390A1 Sterilization, stabilization and preservation of functional biologics
12/18/2003WO2003103389A2 Cryopreservation of haptenized tumor cells
12/18/2003WO2003084995A3 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
12/18/2003WO2003082897A3 Synthetic active peptide fragments
12/18/2003WO2003078640A3 Recombinant drug-sensitive vaccinia virus as smallpox vaccine
12/18/2003WO2003074558A3 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
12/18/2003WO2003072599A3 Novel chemokine binding peptides capable of modulating the biological activity of chemokines
12/18/2003WO2003070271A3 Novel complexes for inducing an immune response
12/18/2003WO2003061520A3 Methods of modulating angiogenesis
12/18/2003WO2003059953A3 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies
12/18/2003WO2003058248A3 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
12/18/2003WO2003057159A3 Psoriasin expression by breast epithelial cells
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003051907A3 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
12/18/2003WO2003051401A3 Stabilised mrna tumour vaccine
12/18/2003WO2003051307A3 Materials and methods for the treatment or prevention of obesity
12/18/2003WO2003050108A8 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
12/18/2003WO2003050064B1 Mitotic kinesin inhibitors
12/18/2003WO2003046179A3 G-protein coupled receptor lustr2 and uses thereof
12/18/2003WO2003045428A3 Use of a technically modified cell as a vaccine for treating tumoral disease
12/18/2003WO2003044047A3 Virulence proteins of the genus yersinia and uses thereof
12/18/2003WO2003040726A3 Screening for hepatitis c virus entry inhibitors
12/18/2003WO2003037164A3 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
12/18/2003WO2003029427A3 Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2
12/18/2003WO2003026692A3 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex
12/18/2003WO2003026578A3 Pine cone extracts and uses thereof
12/18/2003WO2003024304A3 Detection and treatment of cancers of the liver
12/18/2003WO2003009817B1 Stable lyophilized pharmaceutical formulation of igg antibodies
12/18/2003WO2003006045A3 Cxcl10 treatment of secondary tissue degeneration
12/18/2003WO2003004684A9 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES
12/18/2003WO2003002068A3 Diagnosis and treatment of cancer
12/18/2003WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/18/2003WO2002097034A3 Antibodies and antigens of hiv viremia controllers
12/18/2003WO2002092788A3 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
12/18/2003WO2002089731A3 Agents for treatment of hcv and methods of use
12/18/2003WO2002083030A3 Bifunctional energy-reversible acyl-compositions
12/18/2003WO2002079474A3 Human b7 polypeptides
12/18/2003WO2002079231A3 Nucleic acids encoding isav polypeptides
12/18/2003WO2002058723A3 Chemokines as adjuvants of immune response
12/18/2003WO2002040720A8 Compositions and methods relating to ovary specific genes and proteins
12/18/2003WO2002030257A9 Normalization of defective t cell responsiveness through manipulation of thymic regeneration
12/18/2003US20030232976 Comprises nucleotide sequences coding polypeptides for diagnosis, prevention and treatment of meningitis, inflammations, bacterial and pneumonia infections
12/18/2003US20030232780 Composition comprising an immunomodulatory molecule, which molecule comprises an antigen conjugated to an polynucleotide that contains at least one immunostimulatory nucleotide sequence; for modulating an immune response in vertebrates
12/18/2003US20030232758 An amino acid sequences comprises a helper T cell epitope, binding with an antibody or antigen, an immunogenics for inducing the production of antibodies that bind to an amyloid-beta peptide in brian
12/18/2003US20030232392 Comprises soluble liver antigen auto-antibodies; fusion proteins
12/18/2003US20030232373 Pth (polynucleotides and polypeptides of the peptidyl-tRNA hydrolases); utilizing pth polypeptides to screen for antibacterial compounds
12/18/2003US20030232328 Method of detecting antibodies to HCV
12/18/2003US20030232326 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
12/18/2003US20030232074 For stimulating immune activation; for screening immunostimulatory compounds
12/18/2003US20030232061 For therapy of respiratory tract infection in a mammal
12/18/2003US20030232060 Administering an immunizing composition comprising: a carrier; a plasmid encoding an attenuated, doxycycline-inducible proviral molecular clone of the human immunodeficiency virus type 1 (HIV-1), to induce viral expression of the plasmid
12/18/2003US20030232058 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
12/18/2003US20030232057 Method and composition for inducing tolerance to an antigenic material
12/18/2003US20030232055 Innate immune system-directed vaccines
12/18/2003US20030232048 Methods for treating chronic obstructive pulmonary disease (COPD)
12/18/2003US20030232022 P. gingivalis antigenic composition
12/18/2003US20030232010 Improved cytotoxic therapy
12/18/2003US20030232009 Used to block undesirable immune reactions in patients with transplant rejection and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and autoimmune diabetes
12/18/2003CA2493890A1 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
12/18/2003CA2489076A1 Cryopreservation of haptenized tumor cells
12/18/2003CA2489050A1 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells
12/18/2003CA2488774A1 Immunomodulation using altered dendritic cells
12/18/2003CA2488385A1 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
12/18/2003CA2487943A1 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003CA2487907A1 Immunogenic compositions comprising a xenogenic prostate protein p501s
12/18/2003CA2487831A1 Immunogenic compositions
12/18/2003CA2487826A1 Sterilization, stabilization and preservation of functional biologics
12/18/2003CA2487420A1 Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents
12/18/2003CA2487147A1 Combinations comprising epothilones and pharmaceutical uses thereof
12/18/2003CA2486584A1 Compositions and methods for treating diabetes
12/18/2003CA2486118A1 Flexible vaccine assembly and vaccine delivery platform
12/18/2003CA2485874A1 T cell receptor cdr3 sequences and methods for detection
12/18/2003CA2473321A1 Flavivirus vaccines
12/17/2003EP1371730A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
12/17/2003EP1371728A1 Gene encoding adseverin
12/17/2003EP1371664A1 Wti modified peptide
12/17/2003EP1371660A1 Vaccine
12/17/2003EP1371375A1 Vaccine to protect animals against leishmania
12/17/2003EP1371374A1 Immunotherapy of chronic infections and of malignant diseases
12/17/2003EP1370675A1 Novel nucleic acids and polypeptides
12/17/2003EP1370668A2 Leporipox-based vector vaccines
12/17/2003EP1370666A2 Genetic immunisation against cervical carcinoma
12/17/2003EP1370662A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
12/17/2003EP1370661A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370658A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
12/17/2003EP1370640A1 Lactic acid bacteria as agents for treating and preventing allergy
12/17/2003EP1370589A2 Rationally designed antibodies
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370587A2 Antiangiogenic peptides derived from endostatin
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370581A2 Recombinant p. vivax merozoite protein-1 p42 vaccine
12/17/2003EP1370577A2 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
12/17/2003EP1370575A2 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
1 ... 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 ... 1823